by tjackson | Mar 1, 2023 | Presentations and Publications
SYMPOSIUM–TRANSLATIONAL DRUG DISCOVERY: THE VALUE OF ANIMAL MODELS AND ORGANOIDS Wednesday March 29 HALL G3 14:45-15:00 MODELING LATE-ONSET ALZHEIMER’S DISEASE IN MICE SYMPOSIUM–SELECTIVE VULNERABILITY, GLIAL CELLS AND MECHANISMS OF NEURDEGENERATION...
by tjackson | Nov 1, 2019 | Uncategorized
The Preclinical Testing Core (PTC) of the MODEL-AD) consortium supports preclinical screening of test compounds nominated by the greater research community. The PTC has established a streamlined preclinical drug testing strategy with go/no-go decision points that...
by tjackson | Sep 5, 2019 | Uncategorized
Monday, October 21, 2019 Session #354 – 4:15-4:30 PM – McCormick Place: Room S103 Title: Developing mouse models to study late-onset Alzheimer’s Disease D. BAGLIETTO-VARGAS1,2, L. CAI1, M. NGUYEN1, K. HUYNH1, A.C. MARTINI1, L. TRUJILLO-ESTRADA1, C. SOTO3, I....
by tjackson | Jun 27, 2019 | Uncategorized
Sunday, July 14, 4:55-5:15 PM, Petree Hall C #F1-07-03 Alzheimer’s Susceptibility Genes Implicate Microglial Activity Julie Williams, PhD1,2; Rebecca Sims, PhD3; Philip Taylor, PhD2; Michael Sasner, PhD4; Harriet M Williams, MPhil4 and Gareth Howell, PhD3,4, (1)UK...
by tjackson | Jun 27, 2019 | Uncategorized
Preuss C, Pandey R, Piazza E, Fine A, Uyar A, Perumal T, Garceau D, Kotredes KP, Williams H, Mangravite LM, Lamb BT, Oblak AL, Howell GR, Sasner M, Logsdon BA, Carter GW. A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease....
